Burak Atlas

Burak Atlas

Auto-generated profile, based on publicly available information

Burak Atlas

Dicle University, Turkey

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Acta Cirurgica Brasileira
Verified
Journal Article
Open access
PDF file
RÇRıdvan Çetin
Rıdvan Çetin
SBSinan Bahadir
Sinan Bahadir
IBİbRahim Basar
İbRahim Basar
BABarış Aslanoglu
Barış Aslanoglu
BABurak Atlas
Burak Atlas
YTYahya Turan
Yahya Turan
To evaluate the neuroprotective effect of resveratrol, urapidil, and a combined administration of these drugs against middle cerebral artery occlusion (MCAO) induced ischemia/reperfusion (IR) injury model in rats.

1 January 2025 in Acta Cirurgica Brasileira
Verified
Journal Article
Open access
AÇAziz Çevik
Aziz Çevik
BABurak Atlas
Burak Atlas
GEGamze Erdoğan
Gamze Erdoğan
MAMehmet Salih Atama
Mehmet Salih Atama
BABarış Altun
Barış Altun
TYTevfik Yılmaz
Tevfik Yılmaz
Purpose: To investigate the protective effect of trans-anethole in experimental traumatic brain injury (TBI) in mice. Methods: Thirty-five adult mice were divided into five groups (control, TBI, TBI+A40, TBI+A80, and TBI+A160). No treatment was performed in the control group. The treated groups (TBI+A40, TBI+A80, and TBI+A160) received 40, 80 or 160 mg/kg trans-anethole treatment, respectively. At the end of the experiment, the brains of the sacrificed animals were removed, and laboratory analyses were performed. Results: Malondialdehyde (MDA) levels in brain tissue of TBI and TBI+A40 were significantly increased, while MDA levels of TBI+A80 and TBI were similar. TBI+A160 and control tissue MDA levels were similar (p > 0.05), significantly different from TBI (p < 0.01). Immunodensity analyses showed that there was a significant difference between the control and TBI in terms of Bax, caspase 3, tumor necrosis factor-α (TNF-α) and interleukin- (IL)-1β immunoexpression. TBI+A40 immunoexpression was similar to TBI (p > 0.05), significantly different from the control groups (p < 0.05). In TBI+A80 and TBI+A160, pro-apoptotic Bax and caspase 3, pro-inflammatory TNF-α and IL-1β levels were also significantly improved. Immunoexpression levels of TBI+A160 and control were similar (p > 0.05). Conclusion: in our study, trans-anethole treatment had a dose-dependent neuroprotective potential against trauma-induced neurodegeneration.